RoomsLibraryToursPeopleCompareSourcesAbout
Gemini
All Rooms
Compare Engine
Structural Mechanism Alignment

OpenAI Non-Profit to For-Profit vs Purdue Pharma & The Sacklers

The purpose of compare mode is to show that institutional evasion is not accidental personality quirk, but a reproducible bureaucratic playbook. When Meta renames “pirate” to “external” and OpenAI renames “#excise-libgen” to “#project-clear”, they are executing the exact same linguistic maneuver.

mission-splitAligned Mechanism
2 vs 0 instances
OpenAI Non-Profit to For-ProfitRoom ↗

Tech belongs to the world vs startup compensation

Public:OpenAI is a non-profit artificial intelligence research company. Our goal is to advance digital intelligence in the way that is most likely to benefit humanity as a whole, unconstrained by a need to generate financial return.

Private:We need to structure a startup-like equity compensation plan or researchers will simply take the $2M offers at DeepMind. The non-profit structure is great for optics and mission, but we need equity upside to retain talent.

Founding correspondence released in Musk v. AltmanRead pair →

I hold no equity in OpenAI

Public:I have no equity in OpenAI. I make enough money for health insurance and that's it. I do this because I love the work.

Private:Transitioning OpenAI from a non-profit-controlled entity into a Delaware public benefit corporation, creating an equity stake for CEO Sam Altman valued at tens of billions of dollars.

Corporate transition plan leaked to Reuters / BloombergRead pair →
Purdue Pharma & The SacklersRoom ↗

No divergence in this room mapped to this mechanism.

walk-backAligned Mechanism
1 vs 0 instances
OpenAI Non-Profit to For-ProfitRoom ↗

Open source charter vs proprietary moat

Public:We were wrong to be open source in the past. As models become more powerful, safety dictates that sharing weights is a bad idea. Closed models are about safety.

Private:Exclusive commercial licensing of model weights to Microsoft is vital to secure the multi-billion-dollar compute allocations required to maintain competitive dominance against Google.

Microsoft Partnership Governance AgreementRead pair →
Purdue Pharma & The SacklersRoom ↗

No divergence in this room mapped to this mechanism.

testimony-gapAligned Mechanism
1 vs 1 instances
OpenAI Non-Profit to For-ProfitRoom ↗

Musk and Altman struggle over the steering wheel

Public:Elon Musk will depart the board as OpenAI enters an advanced phase. This will eliminate a potential future conflict of interest with Tesla's self-driving AI work.

Private:Musk: 'OpenAI has zero chance of beating Google DeepMind without massive capital. My assessment is that OpenAI should be attached to Tesla as its cash cow.' Altman & Brockman: 'We cannot agree to Elon having full control and majority ownership.'

Internal email correspondenceRead pair →
Purdue Pharma & The SacklersRoom ↗

Mapping corrupt pharmacies and pill mills

Public:Purdue had no insight or mechanism to know whether legitimate pharmacies were being utilized for illicit diversion. When we discovered suspicious prescribers, we acted promptly.

Private:Doctor X in Myrtle Beach is prescribing hundreds of thousands of 80mg tablets per month with cash-only queues around the block. Sales reps noted the clinic is a blatant pill mill, yet orders were approved and deliveries expedited to meet quarterly budget targets.

Internal Diversion Database EntriesRead pair →
values-afterAligned Mechanism
0 vs 1 instances
OpenAI Non-Profit to For-ProfitRoom ↗

No divergence in this room mapped to this mechanism.

Purdue Pharma & The SacklersRoom ↗

Hammer on the abusers

Public:OxyContin provides 12 hours of smooth, continuous pain relief. Clinical studies demonstrate that the risk of addiction in legitimate pain patients is exceedingly rare (under 1%).

Private:We have to hammer on the abusers in every way possible. They are the culprits and the problem. They are reckless criminals who steal our product and ruin it for legitimate sufferers.

Confidential email to Purdue executivesRead pair →
advertorialAligned Mechanism
0 vs 1 instances
OpenAI Non-Profit to For-ProfitRoom ↗

No divergence in this room mapped to this mechanism.

Purdue Pharma & The SacklersRoom ↗

Pushing 80mg dosage for sales bonuses

Public:Dosing decisions must be individualized strictly according to patient pain severity and medical judgment, with safety and clinical titration leading the way.

Private:Target doctors who prescribe 20mg and push them to titrate up to 80mg and 160mg tablets. The 80mg dose is where our highest profit margins live. Sales reps who convert low-dose prescribers will receive double bonus points and luxury resort trips.

Internal Sales Contest Memo ('Toppers' Incentive Program)Read pair →